Skip to main content

FDA wants COVID boosters targeting Omicron BA.4, BA.5 subvariants

The FDA has recommended COVID-19 vaccine manufacturers change the design of their booster shots to combat the Omicron BA.4 and BA.5 subvariants of the coronavirus.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.